DanDouerMD

Hematology • New York, NY

Physician

Join to view full profile

Dr. Douer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Douer's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-2471

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1976

Certifications & Licensure

CA State Medical License 1980 - 2026
NY State Medical License 2011 - 2018

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Intensified Post Remission Therapy Containing PEG-Asparaginase Start of enrollment: 2004 Jul 01
Completed
Phase 2
Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia Start of enrollment: 2002 Apr 01
Terminated
Phase 2
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia Start of enrollment: 2010 May 01
Withdrawn
Phase 2
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies Start of enrollment: 2005 Jul 01
Completed
Phase 1
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 01
Active, not recruiting
Phase 2
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Start of enrollment: 2015 Oct 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impact...
Jose Tinajero, Sharon Xu, Dat Ngo, Shanpeng Li, Joycelynne Palmer
British Journal of Haematology. 2024-11-06
3 citations
Asparaginase: How to Better Manage Toxicities in Adults.
Hoda Pourhassan, Dan Douer, Vinod Pullarkat, Ibrahim Aldoss
Current Oncology Reports. 2023-01-01
6 citations
SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL.
Ibrahim Aldoss, Hoda Pourhassan, Dan Douer
Clinical Lymphoma, Myeloma & Leukemia. 2022-11-01

Lectures

New Data and Paradigms in ALL: Insights and Applications
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Grant Support

Il-12-Faciliated Hematopoietic Recovery Following Myeloablative TherapyNational Cancer Institute2007
Uses Of IL-12 As A Hematological Adjuvant Cancer TherapyNational Cancer Institute2006
Arsenic Trioxide And Vitamin C In AMLNational Cancer Institute2004–2005
Uses Of IL-12 As A Hematological Adjuvant Cancer TherapyNational Cancer Institute2004
Compassionate Use Of Arsenic Trioxide In Relapsed Acute Promyelocytic LeukemiaNational Center For Research Resources2000

Professional Memberships

American Society of Hematology - ASH
Member
American Society of Clinical Oncology - ASCO
Member

Other Languages

Hebrew